Comparison of AAV1 and AAV5 viral vector serotypes and four promoters for viral transduction of the corticospinal tract

被引:0
|
作者
Nieuwenhuis, B. [1 ,2 ]
Haenzi, B. [1 ]
Hilton, S. [1 ]
Verhaagen, J. [2 ]
Fawcett, J. W. [1 ]
机构
[1] Univ Cambridge, Cambridge, England
[2] Netherlands Inst Neuroscience, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P02
引用
收藏
页码:A6 / A6
页数:1
相关论文
共 50 条
  • [31] Hydroxylation of N-acetylneuraminic Acid Influences the In Vivo Tropism of N-linked Sialic Acid-Binding Adeno-Associated Viruses AAV1, AAV5 and AAV6
    Lopez-Gordo, Estrella
    Orlowski, Alejandro
    Wang, Arthur
    Weber, Thomas
    MOLECULAR THERAPY, 2021, 29 (04) : 98 - 98
  • [32] Endothelial cell transduction with recombinant adeno-associated viral (AAV) serotypes: Implications for gene therapy in diabetic macrovascular complications
    Chen, SF
    Kapturczak, M
    Loiler, S
    Song, SH
    Glushakova, O
    Li, CW
    Hauswirth, W
    Berns, K
    Madsen, K
    Samulski, R
    Flotte, T
    Atkinson, M
    Tisher, C
    Agarwal, A
    DIABETES, 2003, 52 : A151 - A152
  • [33] AAV retinal transduction in a large animal model species: Comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vector
    Petersen-Jones, S. M.
    Bartoe, J. T.
    Fischer, A. J.
    Scott, M.
    Boye, S. L.
    Chiodo, V.
    Hauswirth, W. W.
    MOLECULAR VISION, 2009, 15 (194-95): : 1835 - 1842
  • [34] Comparative Transduction Efficiency of AAV Vector Serotypes 1-6 in the Substantia Nigra and Striatum of the Primate Brain
    Markakis, Eleni A.
    Vives, Kenneth P.
    Bober, Jeremy
    Leichtle, Stefan
    Leranth, Csaba
    Beecham, Jeff
    Elsworth, John D.
    Roth, Robert H.
    Samulski, R. Jude
    Redmond, D. Eugene, Jr.
    MOLECULAR THERAPY, 2010, 18 (03) : 588 - 593
  • [35] Trans-neuronal transduction of spinal neurons following cortical injection and anterograde axonal transport of a bicistronic AAV1 vector
    Hutson, T. H.
    Kathe, C.
    Moon, L. D. F.
    GENE THERAPY, 2016, 23 (02) : 231 - 236
  • [36] Comparison of Viral Production, Biodistribution in Mice and Gene Delivery in Human IPS-Derived Myotubes of Different AAV Serotypes
    Gicquel, Evelyne
    Meunier, Pierre
    Hebben, Matthias
    Richard, Isabelle
    MOLECULAR THERAPY, 2018, 26 (05) : 51 - 52
  • [37] Trans-neuronal transduction of spinal neurons following cortical injection and anterograde axonal transport of a bicistronic AAV1 vector
    T H Hutson
    C Kathe
    L D F Moon
    Gene Therapy, 2016, 23 : 231 - 236
  • [38] Circulating Anti-AAV5 Neutralizing Antibody Titers up to 1:1031 Do Not Affect Liver Transduction Efficacy of AAV5 Vectors in Non-Human Primates
    Majowicz, Anna
    Spronck, Lisa
    de Haan, Martin
    Petry, Harald
    Nijmeijer, Bart
    Ferreira, Valerie
    MOLECULAR THERAPY, 2017, 25 (05) : 94 - 94
  • [39] Adeno-associated viral (AAV) vector serotypes transduce a broad host range of human breast cancer cell lines.
    Hoover, F
    Svendsen, A
    Thorsen, F
    Huszthy, P
    Kotin, R
    Afione, S
    Halbert, C
    Miller, AD
    Wilson, J
    Bjerkvig, R
    Lonning, PE
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S101 - S101
  • [40] Capsid engineering overcomes barriers toward Adeno-associated viral (AAV) vector-mediated transduction of endothelial cells
    Zhang, L.
    Rossi, A.
    Lange, L.
    Meumann, N.
    Hacker, U. T.
    Morgan, M.
    Hoffmann, D.
    Schambach, A.
    Salvetti, A.
    Odenthal, M.
    Buening, H.
    HUMAN GENE THERAPY, 2019, 30 (11) : A25 - A25